Article List

WPRIM Management System> DCMS> Acta Pharmaceutica Sinica> 2015> 50> 10

Volume: 50 Issue: 10

1. STUDIES ON THE CONSTITUENTS OF ARTEMISIA ANNUA L.	Page:366—370
2. Identification of antler powder components based on DNA barcoding technology.	Page:1356—1361
3. Cloning and expression of the key enzyme hyoscyamine 6 beta-hydroxylase gene (DaH6H) in scopolamine biosynthesis of Datura arborea.	Page:1346—1355
4. Determination of contact angle of pharmaceutical excipients and regulating effect of surfactants on their wettability.	Page:1342—1345
5. The absorption and metabolism of oxymatrine in rat intestine.	Page:1336—1341
6. An LC-MS/MS method for the simultaneous determination of amygdalin and paeoniflorin in human urine and application to urinary excretion study.	Page:1330—1335
7. Fluorescence enhancement of flavoxate hydrochloride in alkali solution and its application in pharmaceutical analysis.	Page:1324—1329
8. Simultaneous determination of sivelestat and its metabolite XW-IMP-A in human plasma using HPLC-MS/MS.	Page:1318—1323
9. Qualitative analysis of chemical constituents in Si-Wu Decoction based on TCM component database.	Page:1309—1317
10. A new indole derivative from endophyte Myrothecium roridum IFB-E091 in Artemisia annua.	Page:1305—1308
11. Synthesis and biological evaluation of novel pleuromutilin derivatives with nitrogen-containing heterocycles as antibacterial agents.	Page:1297—1304
12. Simultaneous determination of clevidipine butyrate and its metabolite clevidipine acid in dog blood by liquid chromatography-tandem mass spectrometry.	Page:1290—1296
13. Pharmacokinetics and MR imaging of SPIO-shRNA dual functional molecular probe in vivo.	Page:1285—1289
14. Population pharmacokinetic/pharmacodynamic modeling of warfarin by nonlinear mixed effects model.	Page:1280—1284
15. In vitro targeting effect of lactoferrin modified PEGylated liposomes for hepatoma cells.	Page:1272—1279
16. Design, synthesis and antiproliferative activity in cancer cells of novel 18β-glycyrrhetinic acid derivatives.	Page:1263—1271
17. Synthesis and antitumor activity of fluoroquinolon-3-yl-s-triazole sulfide ketones and their derivatives from ciprofloxacin.	Page:1258—1262
18. Sensitization of human colon cancer HT-29 cells to TRAIL-induced apoptosis by gambognic acid.	Page:1252—1257
19. Effects of triptolide on the expression of androgen receptor in human prostate LNCaP cells and its mechanism of action.	Page:1246—1251
20. Effects of paclitaxel loaded-drug micelles on cell proliferation and apoptosis of human lung cancer A549 cells.	Page:1240—1245
21. Mechanism and clinical progress of molecular targeted cancer therapy.	Page:1232—1239
22. Advances in the study of site-specific antibody-drug conjugates.	Page:1225—1231
23. Current applications of dexamethasone for cancer treatment.	Page:1217—1224
24. Advances of the anti-tumor research of metformin.	Page:1210—1216
25. Progress on pharmacokinetic study of antibody-drug conjugates.	Page:1203—1209
26. Progress on pharmacokinetic study of antibody-drug conjugates.	Page:1203—9
27. Advances of the anti-tumor research of metformin.	Page:1210—6
28. Current applications of dexamethasone for cancer treatment.	Page:1217—24
29. Advances in the study of site-specific antibody-drug conjugates.	Page:1225—31
30. Mechanism and clinical progress of molecular targeted cancer therapy.	Page:1232—9
31. Effects of paclitaxel loaded-drug micelles on cell proliferation and apoptosis of human lung cancer A549 cells.	Page:1240—5
32. Effects of triptolide on the expression of androgen receptor in human prostate LNCaP cells and its mechanism of action.	Page:1246—51
33. Sensitization of human colon cancer HT-29 cells to TRAIL-induced apoptosis by gambognic acid.	Page:1252—7
34. Synthesis and antitumor activity of fluoroquinolon-3-yl-s-triazole sulfide ketones and their derivatives from ciprofloxacin.	Page:1258—62
35. Design, synthesis and antiproliferative activity in cancer cells of novel 18β-glycyrrhetinic acid derivatives.	Page:1263—71
36. In vitro targeting effect of lactoferrin modified PEGylated liposomes for hepatoma cells.	Page:1272—9
37. Population pharmacokinetic/pharmacodynamic modeling of warfarin by nonlinear mixed effects model.	Page:1280—4
38. Pharmacokinetics and MR imaging of SPIO-shRNA dual functional molecular probe in vivo.	Page:1285—9
39. Simultaneous determination of clevidipine butyrate and its metabolite clevidipine acid in dog blood by liquid chromatography-tandem mass spectrometry.	Page:1290—6
40. Synthesis and biological evaluation of novel pleuromutilin derivatives with nitrogen-containing heterocycles as antibacterial agents.	Page:1297—304
41. A new indole derivative from endophyte Myrothecium roridum IFB-E091 in Artemisia annua.	Page:1305—8
42. Qualitative analysis of chemical constituents in Si-Wu Decoction based on TCM component database.	Page:1309—17
43. Simultaneous determination of sivelestat and its metabolite XW-IMP-A in human plasma using HPLC-MS/MS.	Page:1318—23
44. Fluorescence enhancement of flavoxate hydrochloride in alkali solution and its application in pharmaceutical analysis.	Page:1324—9
45. An LC-MS/MS method for the simultaneous determination of amygdalin and paeoniflorin in human urine and application to urinary excretion study.	Page:1330—5
46. The absorption and metabolism of oxymatrine in rat intestine.	Page:1336—41
47. Determination of contact angle of pharmaceutical excipients and regulating effect of surfactants on their wettability.	Page:1342—5
48. Cloning and expression of the key enzyme hyoscyamine 6 beta-hydroxylase gene (DaH6H) in scopolamine biosynthesis of Datura arborea.	Page:1346—55
49. STUDIES ON THE CONSTITUENTS OF ARTEMISIA ANNUA L.	Page:366—70
50. Identification of antler powder components based on DNA barcoding technology.	Page:1356—61